U.S. market Closed. Opens in 1 day 10 hours 15 minutes

MRNA | Moderna, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue6.75B19.26B17.74B274.49M48.04M122.51M205.82M108.40M
Cost of Revenue4.69B5.42B2.62B7.93M31.02M454.08MN/AN/A
Gross Profit2.06B13.85B15.12B266.56M17.02M-331.57MN/AN/A
Operating Expenses6.30B4.43B1.82B1.03B593.76M535.78M475.18M332.17M
Selling, General & Admin1.55B1.13B567.00M188.27M109.62M94.25M64.72M57.45M
Research & Development4.84B3.29B1.99B1.37B496.31M454.08M410.46M274.72M
Other Operating Expenses-14.00M-45.00M-735.00M-528.90M-12.17M1.83MN/AN/A
Operating Income-4.24B9.42B13.30B-763.14M-545.72M-413.27M-269.36M-223.77M
Other Expenses / Income-86.00M155.00M-11.00M18.63M31.00M1.83M13.36M8.60M
Before Tax Income-3.94B9.57B13.29B-744.51M-514.72M-384.41M-256.00M-215.17M
Income Tax Expenses772.00M1.21B1.08B2.55M-695.00K326.00K-80.00K1.04M
Net Income-4.71B8.36B12.20B-747.06M-514.02M-384.73M-255.92M-216.21M
Interest Expenses38.00M29.00M18.00M9.89M6.61MN/AN/AN/A
Basic Shares Outstanding382.00M394.00M403.00M381.33M330.80M81.11M269.65M296.68M
Diluted Shares Outstanding382.00M416.00M431.00M381.33M330.80M81.11M269.65M296.68M
EBITDA-3.21B9.77B13.30B-763.14M-545.72M-413.27M-235.46M-200.05M
EBITDA Margin-47.54%50.71%74.97%-278.02%-1,136.06%-337.33%-114.40%-184.56%
EBIT-3.90B9.60B13.30B-734.63M-508.10M-384.41M-256.00M-215.17M
EBIT Margin-57.80%49.86%75.01%-267.63%-1,057.76%-313.77%-124.38%-198.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙